ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Revance Therapeutics Inc

Revance Therapeutics Inc (RVNC)

3.305
-0.265
( -7.42% )
Updated: 10:18:20

Revance Therapeutics Inc Financial Summary

The current RVNC market cap is 291.55M. The company's latest EPS is USD -3.6727 and P/E is -0.97.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 29.02M49.92M49.33M58.13M56.78M
Operating Income -77.48M-144.41M-58.03M-65.5M-139.29M
Net Income -84.69M-145.95M-59.79M-67.32M-141.18M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 413k15.33M77.8M132.57M234.04M
Operating Income -164.46M-273.16M-274.68M-341.96M-316.78M
Net Income -159.43M-282.09M-281.31M-356.42M-323.99M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 711.59M581.9M547.8M597.54M532.49M
Total Liabilities 565.88M569.3M574.47M570.75M638.69M
Total Equity 145.71M12.6M-26.67M26.79M-106.2M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 340.29M720.22M531.16M581.9M478.45M
Total Liabilities 114.8M345.93M462.69M569.3M630.06M
Total Equity 225.49M374.29M68.47M12.6M-151.6M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -163.37M-193.55M-69.5M-122.88M-173.84M
Investing -179.76M-138.8M95.32M55.78M107.37M
Financing 337.87M331.69M3.27M100.74M138.2M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -106.16M-178.5M-221.54M-193.55M-216.58M
Investing -17.59M12.13M-29.67M-138.8M109.74M
Financing 221.66M331.48M29.87M331.69M136.57M
Market Cap 291.55M
Price to Earnings Ratio -0.97
Price to Sales Ratio 1.35
Price to Cash Ratio 2.29
Price to Book Ratio -2.08
Dividend Yield -

Share Statistics

Shares Outstanding 88.21M
Average Volume (1 week) 1.77M
Average Volume (1 Month) 1.59M
52 Week Change -89.43%
52 Week High 37.98
52 Week Low 3.25
Spread (Intraday) 0.01 (0.3%)

Company Info

Company Name Revance Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.revance.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock